Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
3/31/2023
Financial-related Company News Digest (March 2023)
3/28/2023
Chinese Scientists Develop New Vaccine Strategy by Entrapping Live Vir...
3/24/2023
New Report: Incidence of Moderate and Severe Ovarian Hyperstimulation ...
3/6/2023
CNNIC Publishes 51st Statistical Report on Chinese Internet Developmen...
3/3/2023
China: Commercial Health Insurance Trends (Simon Kucher)
2/20/2023
Clover, Adimmune Tie Up to Commercialize Quadrivalent Seasonal Flu Vac...
2/17/2023
Official Translation: Provisions for Supervision and Administration of...
2/15/2023
A Rational Approach to Tapping China's Growing Digital Health Trend (B...
2/13/2023
Clover Launches COVID-19 Booster Vaccine in China
2/8/2023
After Ditching Promising Drug, Everest Medicines Bets on mRNA (The Bam...
2/7/2023
New-Generation Long-Acting Growth Hormone Is A Potential Game Changer ...
2/1/2023
A Comparison of Healthtech Regulations: China (Asia Business Law Journ...
1/31/2023
Daewoong Outlicenses to CS Pharma Its Greater China Rights of Bersipor...
1/31/2023
Chinese Vaccine Market to Surpass $12.16 Billion by 2027: New Report
1/28/2023
J&J, Legend's Carvykti Beat Standard Therapy in Earlier Myeloma, Thre...
1/25/2023
Pharma Cos That Develop Vaccines With Efficacy Against Omicron Variant...
1/20/2023
Funding for Biopharmaceuticals Plummeted in 2022 with Investments Flow...
1/19/2023
After Ditching Promising Drug, Everest Medicines Bets on mRNA (The Bam...
1/18/2023
Moderna in Active Discussions with China to Supply COVID Vaccines
1/13/2023
PhIRDA: Early Stage Financing and Recent Startups Dominate Chinese Pha...
1/12/2023
Fosun Sees Surge in Demand from Mainland Chinese for Omicron-focused B...
1/3/2023
Legend Biotech's NDA for Ciltacabtagene Autoleucel (Cilta-Cel) Accepte...
12/28/2022
Everest Medicines Begins Operations at mRNA Vaccine Production Site in...
12/27/2022
Mainland Chinese May Now Get BioNTech COVID-19 Vaccines in Hong Kong...
12/22/2022
NHSA: Further Reduction of Drug and Medical Consumable Prices to Secur...
12/21/2022
BioNTech Sends First Batch of Vaccine to China for German Residents Th...
12/19/2022
Adagene Announces Clinical Trial Collaboration to Evaluate Anti-CTLA-4...
12/13/2022
China to Roll Out Second COVID Vaccine Booster for High-risk Groups, E...
12/9/2022
China Cracks Down on Drug Price Gouging amid Fears of COVID Spike: Reu...
12/8/2022
China's Reversal of Zero-Covid Policy to Boost Its Healthcare Sector: ...
Page:
7
/
71
Total number of articles:
2126
:
[First]
[<<]
[5]
[6]
[7]
[8]
[9]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit